Get started
Author

Hitoshi Teramoto

Observed names: H Teramoto, H. Teramoto, H., Teramoto, Hitoshi TERAMOTO, Teramoto, H.
ORCID: 0000-0001-6003-1659
Observed ORCID: 0000-0001-6003-1659
OpenAlex ID: A5044985859
The Controlling Nutritional Status Score Serves as a Predictor of Short- and Long-Term Outcomes for Patients with Stage 2 or 3 Gastric Cancer: Analysis of a Multi-institutional Data Set
2018 · Song Ryo, Mitsuro Kanda, et al. · Annals of Surgical Oncology · 81
The Preoperative Prognostic Nutritional Index Predicts Short-Term and Long-Term Outcomes of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-Institution Dataset
2019 · Masahiro Sasahara, Mitsuro Kanda, et al. · Digestive Surgery · 64
Tumor budding as a useful prognostic marker in T1‐stage squamous cell carcinoma of the esophagus
2013 · Hitoshi Teramoto, Masahiko Koike, et al. · Journal of Surgical Oncology · 54
PDF
Multi‐institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer
2019 · Mitsuro Kanda, Seiji Ito, et al. · Cancer Medicine · 53
PDF
Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset
2019 · Koki Nakanishi, Mitsuro Kanda, et al. · Gastric Cancer · 49
PDF
Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset
2018 · Shogo Hayashi, Mitsuro Kanda, et al. · Gastric Cancer · 47
PDF
Intraoperative Blood Loss is Associated with Shortened Postoperative Survival of Patients with Stage II/III Gastric Cancer: Analysis of a Multi‐institutional Dataset
2018 · Yuki Ito, Mitsuro Kanda, et al. · World Journal of Surgery · 46
Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial)
2019 · K Misawa, Y Mochizuki, et al. · British journal of surgery · 34
Propensity-score-matched analysis of a multi-institutional dataset to compare postoperative complications between Billroth I and Roux-en-Y reconstructions after distal gastrectomy
2020 · Koki Nakanishi, Mitsuro Kanda, et al. · Gastric Cancer · 25
PDF
Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer
2019 · Yasuhito Suenaga, Mitsuro Kanda, et al. · World Journal of Gastrointestinal Oncology · 25
PDF
Systemic Inflammation Score as a Predictor of Pneumonia after Radical Resection of Gastric Cancer: Analysis of a Multi-Institutional Dataset
2020 · Michita Shoka, Mitsuro Kanda, et al. · Digestive Surgery · 22
D2 lymph node dissection confers little benefit on the overall survival of older patients with resectable gastric cancer: a propensity score-matching analysis of a multi-institutional dataset
2020 · Takahiro Shinozuka, Mitsuro Kanda, et al. · Surgery Today · 19
Accurate Risk Stratification of Patients with Node‐Positive Gastric Cancer by Lymph Node Ratio
2020 · Shunsuke Nakamura, Mitsuro Kanda, et al. · World Journal of Surgery · 18
Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: Propensity score matching analysis of a multi‐institutional dataset
2018 · Nobuhiko Nakagawa, Mitsuro Kanda, et al. · Cancer Medicine · 14
PDF
Association between Lymphovascular Invasion and Recurrence in Patients with pT1N+ or pT2–3N0 Gastric Cancer: a Multi-institutional Dataset Analysis
2020 · Keizo Fujita, Mitsuro Kanda, et al. · Journal of the Korean Gastric Cancer Association · 13
PDF
Accurate Prediction of Prognosis After Radical Resection of Gastric Cancer by the Modified Systemic Inflammation Score; a Multicenter Dataset Analysis
2021 · Kota Inagaki, Mitsuro Kanda, et al. · World Journal of Surgery · 11
Risk score for predicting death from other causes after curative gastrectomy for gastric cancer
2022 · Yuki Ito, Takashi Miwa, et al. · Gastric Cancer · 10
PDF
Survival times are similar among patients with peritoneal, hematogenous, and nodal recurrences after curative resections for gastric cancer
2020 · Koichi Sawaki, Mitsuro Kanda, et al. · Cancer Medicine · 9
PDF
Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study)
2020 · Goro Nakayama, Nao Takano, et al. · European Journal of Cancer · 8
Proposal of a Scoring Scale to Estimate Risk of the Discontinuation of S‐1 Adjuvant Monotherapy in Patients with Stage II to III Gastric Cancer: A Multi‐Institutional Dataset Analysis
2019 · Akimitsu Iizuka, Mitsuro Kanda, et al. · World Journal of Surgery · 8
Preoperative neutrophil-to-platelet ratio as a potential prognostic factor for gastric cancer with positive peritoneal lavage cytology in the absence of other non-curative factors: a multi-institutional dataset analysis
2022 · Akira Nonogaki, Mitsuro Kanda, et al. · Surgery Today · 7
Short-term outcomes of gastrectomy after neoadjuvant chemotherapy for clinical stage III gastric cancer: propensity score-matched analysis of a multi-institutional database
2020 · Shinichi Umeda, Mitsuro Kanda, et al. · Surgery Today · 7
Tumor size ≥50 mm as an Independent Prognostic Factor for Patients with Stage II or III Gastric Cancer After Postoperative S‐1 Monotherapy: Analysis of a Multi‐institution Dataset
2019 · Masayuki Tsutsuyama, Mitsuro Kanda, et al. · World Journal of Surgery · 7
E-PASS scoring system serves as a predictor of short- and long-term outcomes in gastric cancer surgery
2021 · Koki Nakanishi, Mitsuro Kanda, et al. · Surgery Today · 6
＜Editors' Choice＞ Efficacy of enteral nutrients containing β-hydroxy-β-methylbutyrate, glutamine, and arginine for the patients with anastomotic leakage after gastrectomy: study protocol of a multicenter phase II clinical trial.
2018 · Mitsuro Kanda, Chie Tanaka, et al. · Europe PMC (PubMed Central) · 6
Works count: 46
Citation count: 682
H-index: 14
I10-index: 17
Year
Topic
Type